Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
Titel:
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
Auteur:
Devinsky, Orrin Verducci, Chloe Thiele, Elizabeth A. Laux, Linda C. Patel, Anup D. Filloux, Francis Szaflarski, Jerzy P. Wilfong, Angus Clark, Gary D. Park, Yong D. Seltzer, Laurie E. Bebin, E. Martina Flamini, Robert Wechsler, Robert T. Friedman, Daniel